ACIU logo

AC Immune SA (ACIU) Revenue

Annual Revenue

$16.48 M
+$12.36 M+299.51%

December 31, 2023


Summary


Performance

ACIU Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACIUprofitabilitymetrics:

Quarterly Revenue

$29.47 M
+$28.71 M+3779.82%

September 30, 2024


Summary


Performance

ACIU Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$46.93 M
+$29.47 M+168.79%

September 30, 2024


Summary


Performance

ACIU TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACIUprofitabilitymetrics:

ACIU Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+299.5%--
3 y3 years+0.1%+623.5%+1052.2%
5 y5 years+133.3%-12.6%-57.9%

ACIU Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+299.5%at high>+9999.0%at high+1052.2%
5 y5-year-85.2%+299.5%at high>+9999.0%-57.9%+1052.2%
alltimeall time-85.2%+299.5%-60.9%>+9999.0%-58.0%>+9999.0%

AC Immune SA Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$29.47 M(+3779.8%)
$46.93 M(+168.8%)
Jun 2024
-
$759.60 K(-95.5%)
$17.46 M(+4.5%)
Dec 2023
$16.48 M(+299.5%)
$16.70 M(>+9900.0%)
$16.70 M(+309.9%)
Dec 2022
$4.13 M(-74.9%)
$1000.00(-100.0%)
$4.07 M(+0.0%)
Sep 2022
-
$4.07 M(+290.0%)
$4.07 M(-74.7%)
Dec 2020
$16.46 M(-85.2%)
$1.04 M(-14.5%)
$16.08 M(+1.1%)
Sep 2020
-
$1.22 M(+8.7%)
$15.91 M(-67.1%)
Jun 2020
-
$1.12 M(-91.1%)
$48.39 M(-0.8%)
Mar 2020
-
$12.69 M(+1360.8%)
$48.77 M(-56.2%)
Dec 2019
$111.18 M(+1473.5%)
$868.80 K(-97.4%)
$111.39 M(-0.2%)
Sep 2019
-
$33.70 M(+2136.8%)
$111.65 M(+39.1%)
Jun 2019
-
$1.51 M(-98.0%)
$80.29 M(-0.7%)
Mar 2019
-
$75.31 M(+6591.0%)
$80.84 M(+1044.4%)
Dec 2018
$7.07 M
$1.13 M(-52.0%)
$7.06 M(-68.7%)
Sep 2018
-
$2.34 M(+13.8%)
$22.57 M(+5.7%)
DateAnnualQuarterlyTTM
Jun 2018
-
$2.06 M(+33.9%)
$21.34 M(+6.5%)
Mar 2018
-
$1.54 M(-90.8%)
$20.05 M(-2.2%)
Dec 2017
$20.56 M(-12.7%)
$16.63 M(+1390.3%)
$20.51 M(+286.4%)
Sep 2017
-
$1.12 M(+46.0%)
$5.31 M(-4.5%)
Jun 2017
-
$764.30 K(-61.7%)
$5.56 M(-78.1%)
Mar 2017
-
$2.00 M(+39.8%)
$25.35 M(+6.3%)
Dec 2016
$23.57 M(-42.0%)
$1.43 M(+4.6%)
$23.84 M(+4.9%)
Sep 2016
-
$1.37 M(-93.4%)
$22.73 M(-51.2%)
Jun 2016
-
$20.56 M(+4094.1%)
$46.63 M(+13.4%)
Mar 2016
-
$490.20 K(+54.2%)
$41.10 M(+0.6%)
Dec 2015
$40.62 M(+22.6%)
$317.80 K(-98.7%)
$40.86 M(+0.8%)
Sep 2015
-
$25.26 M(+68.0%)
$40.54 M(+165.3%)
Jun 2015
-
$15.03 M(+5991.2%)
$15.28 M(+6091.2%)
Mar 2015
-
$246.80 K
$246.80 K
Dec 2014
$33.12 M
-
-

FAQ

  • What is AC Immune SA annual revenue?
  • What is the all time high annual revenue for AC Immune SA?
  • What is AC Immune SA annual revenue year-on-year change?
  • What is AC Immune SA quarterly revenue?
  • What is the all time high quarterly revenue for AC Immune SA?
  • What is AC Immune SA TTM revenue?
  • What is the all time high TTM revenue for AC Immune SA?

What is AC Immune SA annual revenue?

The current annual revenue of ACIU is $16.48 M

What is the all time high annual revenue for AC Immune SA?

AC Immune SA all-time high annual revenue is $111.18 M

What is AC Immune SA annual revenue year-on-year change?

Over the past year, ACIU annual revenue has changed by +$12.36 M (+299.51%)

What is AC Immune SA quarterly revenue?

The current quarterly revenue of ACIU is $29.47 M

What is the all time high quarterly revenue for AC Immune SA?

AC Immune SA all-time high quarterly revenue is $75.31 M

What is AC Immune SA TTM revenue?

The current TTM revenue of ACIU is $46.93 M

What is the all time high TTM revenue for AC Immune SA?

AC Immune SA all-time high TTM revenue is $111.65 M